Guardian Pharmacy Services (NYSE:GRDN) Hits New 1-Year High – Should You Buy?

Guardian Pharmacy Services, Inc. (NYSE:GRDN) reached a new 52-week high on Tuesday . The stock traded as high as $47.04 and last traded at $47.0070, with a volume of 80098 shares changing hands. The stock had previously closed at $46.49.

Wall Street Analyst Weigh In

Several research firms recently weighed in on GRDN. Truist Financial increased their price target on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Oppenheimer boosted their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Weiss Ratings raised shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Bank of America raised their target price on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Finally, Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $43.83.

Guardian Pharmacy Services Price Performance

The firm has a fifty day moving average price of $40.32 and a two-hundred day moving average price of $38.76. The stock has a market capitalization of $2.31 billion, a PE ratio of 45.04, a P/E/G ratio of 2.49 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $351.77 million during the quarter, compared to analyst estimates of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. On average, research analysts expect that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

A number of large investors have recently made changes to their positions in GRDN. Jennison Associates LLC increased its holdings in Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock worth $30,986,000 after purchasing an additional 706,823 shares during the period. Braun Stacey Associates Inc. purchased a new stake in shares of Guardian Pharmacy Services in the 2nd quarter worth $14,234,000. Ranger Investment Management L.P. bought a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth $7,263,000. Dimensional Fund Advisors LP grew its position in shares of Guardian Pharmacy Services by 200.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after buying an additional 139,070 shares in the last quarter. Finally, Sei Investments Co. increased its stake in shares of Guardian Pharmacy Services by 40.5% during the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after buying an additional 103,177 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.